Surgical Strategies and Prognostic Factors in Invasive Bladder Cancer: A Systematic Review
Keywords:
Invasive Bladder Cancer, Surgical Strategies, Prognostic FactorsAbstract
Background: Invasive bladder cancer presents a substantial health challenge due to its aggressive nature and high incidence. Surgical management, primarily through open radical cystectomy (ORC), laparoscopic radical cystectomy (LRC), and robotic-assisted radical cystectomy (RARC), is essential in treating this malignancy. Understanding the comparative outcomes of these surgical approaches and identifying prognostic factors is crucial to optimize patient care. Methods: This systematic review synthesized data from studies meeting specific inclusion criteria focused on the outcomes of ORC, LRC, and RARC for invasive bladder cancer. Major databases, including Emerald, Science Direct, and Sagepub, were searched to collate relevant studies. Key aspects analyzed included perioperative outcomes, oncological results, and the influence of prognostic factors such as lymph node dissection and surgical margin status. Results: The review revealed that minimally invasive techniques, namely LRC and RARC, demonstrate comparable oncologic outcomes to ORC, with distinct advantages in perioperative recovery, including reduced blood loss and shorter hospital stays. Prognostic factors like extensive lymph node dissection and achieving negative surgical margins were associated with improved survival and recurrence rates. Conclusion: The findings support that the choice of surgical approach should be tailored based on patient-specific factors and institutional expertise to enhance outcomes. High-quality, individualized surgical care is paramount, emphasizing the role of centralizing bladder cancer surgeries to high-volume centers and establishing referral networks for optimal patient management.
References
J. J. Meeks et al., “A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer,” Eur Urol, vol. 62, no. 3, pp. 523–533, Sep. 2012, doi: 10.1016/j.eururo.2012.05.048.
J. Wu, R.-Y. Xie, C.-Z. Cao, B.-Q. Shang, H.-Z. Shi, and J.-Z. Shou, “Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature,” Front Oncol, vol. 12, Apr. 2022, doi: 10.3389/fonc.2022.816444.
G. Gakis et al., “ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder,” Eur Urol, vol. 63, no. 1, pp. 45–57, Jan. 2013, doi: 10.1016/j.eururo.2012.08.009.
G. Arcangeli, L. Strigari, and S. Arcangeli, “Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials,” Crit Rev Oncol Hematol, vol. 95, no. 3, pp. 387–396, Sep. 2015, doi: 10.1016/j.critrevonc.2015.04.006.
R. Ghandour, N. Singla, and Y. Lotan, “Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer,” Trends Cancer, vol. 5, no. 7, pp. 426–439, Jul. 2019, doi: 10.1016/j.trecan.2019.05.011.
D. C. Snow-Lisy et al., “Robotic and Laparoscopic Radical Cystectomy for Bladder Cancer: Long-term Oncologic Outcomes,” Eur Urol, vol. 65, no. 1, pp. 193–200, Jan. 2014, doi: 10.1016/j.eururo.2013.08.021.
T. H. Kim et al., “Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches,” J Endourol, vol. 30, no. 7, pp. 783–791, Jul. 2016, doi: 10.1089/end.2015.0652.
M. Pere, A. Amantakul, S. Sriplakich, and T. Tarin, “Optimizing surgical outcomes in bladder cancer patients undergoing radical cystectomy,” Front Surg, vol. 9, Mar. 2023, doi: 10.3389/fsurg.2022.1008318.
H. M. Bruins et al., “The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel,” Eur Urol Oncol, vol. 3, no. 2, pp. 131–144, Apr. 2020, doi: 10.1016/j.euo.2019.11.005.
J. Zhong et al., “Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation,” Am J Clin Oncol, vol. 42, no. 1, 2019, [Online]. Available: https://journals.lww.com/amjclinicaloncology/fulltext/2019/01000/comparison_of_outcomes_in_patients_with.7.aspx
J. C. Hu et al., “Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study,” Eur Urol, vol. 70, no. 1, pp. 195–202, Jul. 2016, doi: 10.1016/j.eururo.2016.03.028.
D. J. Parekh et al., “Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial,” The Lancet, vol. 391, no. 10139, pp. 2525–2536, Jun. 2018, doi: 10.1016/S0140-6736(18)30996-6.
K. Matsumoto et al., “Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience,” Asian J Surg, vol. 42, no. 1, pp. 189–196, Jan. 2019, doi: 10.1016/j.asjsur.2017.11.002.
B. J. Challacombe et al., “The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer With Special Emphasis on Cancer Control and Complications,” Eur Urol, vol. 60, no. 4, pp. 767–775, Oct. 2011, doi: 10.1016/j.eururo.2011.05.012.
P. Adamczyk, K. Juszczak, M. Kadłubowski, A. Ostrowski, P. Maciukiewicz, and T. Drewa, “Can laparoscopic cystectomy become the method of choice in the treatment of invasive urothelial urinary bladder cancer?,” Advances in Clinical and Experimental Medicine, vol. 29, no. 3, pp. 301–304, Mar. 2020, doi: 10.17219/acem/115084.
A. G. Bachman et al., “Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database,” Urology, vol. 103, pp. 99–105, May 2017, doi: 10.1016/j.urology.2017.02.018.
J. P. Stein et al., “Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients,” Journal of Clinical Oncology, vol. 19, no. 3, pp. 666–675, Feb. 2001, doi: 10.1200/JCO.2001.19.3.666.
A. B. Smith et al., “Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients,” Journal of Laparoendoscopic & Advanced Surgical Techniques, vol. 22, no. 1, pp. 17–21, Jan. 2012, doi: 10.1089/lap.2011.0326.
Z. A. Dotan et al., “Positive Surgical Margins in Soft Tissue Following Radical Cystectomy for Bladder Cancer and Cancer Specific Survival,” Journal of Urology, vol. 178, no. 6, pp. 2308–2313, Dec. 2007, doi: 10.1016/j.juro.2007.08.023.
D. Canter et al., “A Thorough Pelvic Lymph Node Dissection in Presence of Positive Margins Associated With Better Clinical Outcomes in Radical Cystectomy Patients,” Urology, vol. 74, no. 1, pp. 161–165, Jul. 2009, doi: 10.1016/j.urology.2009.01.024.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 T. Nirza Vardoeli, Neza Aulina (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
